Authentication in Pharmaceuticals

A 5-step risk assessment strategy

Download the Whitepaper

Increase Revenue. Gain Competitive Advantage.

Protect Brand Value.

Counterfeit pharmaceuticals are a $200 billion annual business, linked to approximately one million deaths each year. To close the gap, it is vital to ensure the integrity of your pharmaceutical supply chain and protect product lines.

While you may not be able to fully prevent counterfeiting, you can limit the risks by taking a proactive approach. In this whitepaper, Authentix shares a five-step risk assessment strategy to ensure consistent and sustainable authentication of your pharmaceuticals.

Key Takeaways:

  • How to utilize a risk inventory and multi-factor risk categories to identify vulnerabilities in your supply chain
  • The brand value of a proactive approach when facing a high-profile incident of counterfeiting
  • Why data-based improvements are essential for a sustainable authentication solution

In pharmaceuticals, counterfeiting is a ‘not if, but when’ incident which can have lasting impact on both your product lines and consumer trust. Learn a proactive approach to the growing threat of counterfeit pharmaceuticals.

Download the Whitepaper

  • Fuel authentication program helps Serbia recover
    millions in lost excise taxes

    More than 930 million liters of fuel marked, and the Serbian government began to see significant evidence that the program was working.

    Read Case Study

  • Major US Fuel Marketer Protects its Brand Promise
    and Revenue Stream

    The oil company has experienced a 7% decrease in failure rate directly attributed to a reduction in the commingling of non-branded gasoline with branded product.

    Read Case Study

  • Level 3 Security Features and Currency

    Counterfeiting put one of the world’s largest economies at risk when rates reached nearly 300 counterfeits per million notes.

    Read Case Study

  • How One Country Increased Excise Tax Collection

    Learn how one African nation overcame under reporting of production volumes and product smuggling of tobacco, spirits, beer, soda and bottled water.

    Read Case Study

  • Pharmaceutical Counterfeits Threaten $1 Billion Pipeline of Product

    Counterfeit copies of major pharmaceutical brand were discovered in the US market. With no security measures in place to allow patients or inspectors to easily identify counterfeit goods.

    Read Case Study